Another FDA vs uniQure Episode

The Business Brew by Bill Brewster

May 7, 202601:20:52Business

Peter Mantas returns to the show. This is a follow up episode to the episode discussing uniQure. It's timely given the amount of media attention Marty Makary is getting; in part because of uniQure. Describing his trip on...

Related Episodes

Continue listening to more episodes from The Business Brew.

Another Cyclical Masterclass with Robotti & Company

Aug 27, 2026 - 01:38:56

Bob Robotti stops by for a follow up episode. David Kessler, Portfolio Manager and Securities Analyst at...

Revisiting Fairfax Financial

Apr 30, 2026 - 01:31:42

Charles Frischer and Asheef Lalani stop by The Business Brew to update the listeners on Fairfax Financial...

Evan Tindell

Apr 24, 2026 - 01:37:56

Evan Tindell, CIO at Bireme Capital , returns to The Brew for a laid back conversation. The impetus for t...

Sonu Chawla - Managing Mid Cap Exposure - $TSCM

Mar 26, 2026 - 01:12:15

Sonu Chawla of Times Square Capital Management shares her investment philosophy, focusing on growth with...

Notes From The Beauty Contest

Mar 21, 2026 - 01:51:23

@crashkolnikov on X, and author of Notes From The Beauty Contest Substack , joins the show. Notes From Th...

Current Events - uniQure and the FDA

Mar 6, 2026 - 01:35:14

uniQure is a business that develops gene therapies. uniQure's AMT-130 is currently in the headlines. This...

Jacob Shapiro - A "Geopolitical Cousin" Joins the Show

Mar 6, 2026 - 01:02:53

Jacob Shapiro is a geopolitical analyst who provides strategic guidance to families, investors, and corpo...

Investing Unscripted

Feb 13, 2026 - 01:26:22

Jeff and Jason, from the Investing Unscripted podcast, stop by the show for some general investment bante...